Protara Therapeutics Statistics
Total Valuation
TARA has a market cap or net worth of $49.10 million. The enterprise value is -$29.11 million.
Important Dates
The last earnings date was Tuesday, November 12, 2024, before market open.
Earnings Date | Nov 12, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
TARA has 20.63 million shares outstanding. The number of shares has increased by 46.80% in one year.
Current Share Class | 20.63M |
Shares Outstanding | 20.63M |
Shares Change (YoY) | +46.80% |
Shares Change (QoQ) | +5.16% |
Owned by Insiders (%) | 7.61% |
Owned by Institutions (%) | 34.89% |
Float | 15.48M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 0.58 |
P/TBV Ratio | 0.58 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 9.85, with a Debt / Equity ratio of 0.06.
Current Ratio | 9.85 |
Quick Ratio | 9.43 |
Debt / Equity | 0.06 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -52.97% and return on invested capital (ROIC) is -33.90%.
Return on Equity (ROE) | -52.97% |
Return on Assets (ROA) | -31.42% |
Return on Capital (ROIC) | -33.90% |
Revenue Per Employee | n/a |
Profits Per Employee | -$1.56M |
Employee Count | 27 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +100.87% in the last 52 weeks. The beta is 1.79, so TARA's price volatility has been higher than the market average.
Beta (5Y) | 1.79 |
52-Week Price Change | +100.87% |
50-Day Moving Average | 2.09 |
200-Day Moving Average | 2.67 |
Relative Strength Index (RSI) | 49.55 |
Average Volume (20 Days) | 187,295 |
Short Selling Information
The latest short interest is 2.74 million, so 13.27% of the outstanding shares have been sold short.
Short Interest | 2.74M |
Short Previous Month | 2.32M |
Short % of Shares Out | 13.27% |
Short % of Float | 17.69% |
Short Ratio (days to cover) | 14.46 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -45.88M |
Pretax Income | -40.69M |
Net Income | -42.05M |
EBITDA | -45.53M |
EBIT | -45.88M |
Earnings Per Share (EPS) | -$2.53 |
Full Income Statement Balance Sheet
The company has $81.50 million in cash and $4.74 million in debt, giving a net cash position of $76.76 million or $3.72 per share.
Cash & Cash Equivalents | 81.50M |
Total Debt | 4.74M |
Net Cash | 76.76M |
Net Cash Per Share | $3.72 |
Equity (Book Value) | 81.79M |
Book Value Per Share | 3.96 |
Working Capital | 76.44M |
Full Balance Sheet Cash Flow
Operating Cash Flow | n/a |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |